Catalent Pharma Solutions Licenses Innovative Taste-Masking Technology for Bitter Drugs Following R&D Collaboration With New Jersey Institute of Technology (NJIT)  
10/10/2012 10:07:26 AM

SOMERSET, N.J.--(BUSINESS WIRE)--Following a successful research collaboration, Catalent Pharma Solutions announces that it has taken an exclusive license to innovative taste-masking technology developed by the New Jersey Institute of Technology (NJIT). The technology has been developed to mask the most challenging, unpleasant and bitter tasting pharmaceutical active ingredients.